Suppr超能文献

采用体外光化学疗法和静脉注射免疫球蛋白治疗难治性坏死性黄色肉芽肿。

Treatment of refractory necrobiotic xanthogranulomas with extracorporeal photopheresis and intravenous immunoglobulin.

作者信息

Liszewski Walter, Wisniewski Joy D, Safah Hana, Boh Erin E

机构信息

Tulane University School of Medicine, Tulane University, New Orleans, Louisiana.

出版信息

Dermatol Ther. 2014 Sep-Oct;27(5):268-71. doi: 10.1111/dth.12135. Epub 2014 Jun 9.

Abstract

Necrobiotic xanthogranuloma (NXG) is a disease of fibrotic or telangiectatic granulomatous papules and nodules that can ultimately progress into ulcerated plaques. Although the exact cause of NXG is unknown, it most often occurs in patients with paraproteinemia secondary to a hematologic disease. Consequently, therapy for NXG is targeted at treating the underlying hematologic disease, and subsequent paraproteinemia, with alkylating agents, antimetabolites, radiation, and/or immunosuppressive agents. Cases refractory to these therapies often have poor outcomes. We report the successful treatment of two patients with refractory NXG with two different modalities: extracorporeal photopheresis (ECP) and intravenous immunoglobulin (IVIG). The first case shows a patient without paraproteinemia who had success with ECP and IVIG, and the second is a patient with paraproteinemia treated effectively with IVIG. The beneficial response of our patients to IVIG, as well as ECP, shows that they may be an effective treatment option for refractory NXG.

摘要

坏死性黄色肉芽肿(NXG)是一种由纤维化或毛细血管扩张性肉芽肿性丘疹和结节构成的疾病,最终可发展为溃疡性斑块。尽管NXG的确切病因尚不清楚,但它最常发生于继发于血液系统疾病的副蛋白血症患者。因此,NXG的治疗旨在使用烷化剂、抗代谢药物、放疗和/或免疫抑制剂来治疗潜在的血液系统疾病以及随之而来的副蛋白血症。对这些治疗无效的病例往往预后不佳。我们报告了两例难治性NXG患者分别通过两种不同方式成功治疗的病例:体外光化学疗法(ECP)和静脉注射免疫球蛋白(IVIG)。第一例是一名无副蛋白血症的患者,通过ECP和IVIG治疗取得成功;第二例是一名通过IVIG有效治疗的副蛋白血症患者。我们的患者对IVIG以及ECP的良好反应表明,它们可能是难治性NXG的有效治疗选择。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验